Los Angeles Times

Melody Petersen

Writer

Melody Petersen covers biotechnology for the Los Angeles Times. Previously, she wrote about the pharmaceutical industry for the New York Times. She won a Loeb award for reporting about a power company at the San Jose Mercury News. She has also written for the Orange County Register and the Philadelphia Inquirer. She’s the author of Our Daily Meds, a book about the drug industry. She’s a former certified public accountant and grew up on an Iowa farm.

Recent Articles

  • In latest stumble, Theranos retracts blood tests

    In latest stumble, Theranos retracts blood tests

    Rather than disrupting America’s blood-testing industry, as it has repeatedly promised, beleaguered biotech start-up Theranos has disrupted care for some patients. Desperate to stop the shutdown of its California lab, Theranos told federal regulators that it is retracting the results of tens of...

  • State found lapses in infection control at UCLA and Cedars-Sinai

    State found lapses in infection control at UCLA and Cedars-Sinai

    After "super bug" outbreaks last year involving a hard-to-clean medical scope, state health inspectors descended on two of Los Angeles’ largest hospitals and found numerous safety violations that appeared to put far more patients at risk. At UCLA Ronald Reagan Medical Center, the state declared...

  • Herbalife estimates possible FTC settlement could reach $200 million

    Herbalife estimates possible FTC settlement could reach $200 million

    Herbalife said Thursday that the company could pay as much as $200 million if it settles its dispute with federal trade regulators, who are investigating its business practices. The Los Angeles nutritional supplement maker said that talks with the Federal Trade Commission have reached “an advanced...

  • 3 patients died in a Pasadena outbreak possibly caused by medical scopes

    3 patients died in a Pasadena outbreak possibly caused by medical scopes

    At least three patients died last year at Huntington Hospital in Pasadena in an outbreak suspected to have been caused by tainted medical scopes, according to a newly discovered regulatory report. Huntington hospital officials had confirmed in August that three patients were sickened the previous...

  • L.A. billionaire Soon-Shiong gets $148-million payday even as his firm's stock tanks

    L.A. billionaire Soon-Shiong gets $148-million payday even as his firm's stock tanks

    Even though its shares have tanked, the Southern California biotech firm NantKwest Inc. gave its top executive, Patrick Soon-Shiong, a pay package last year worth almost $148 million, according to a stock filing Wednesday. Soon-Shiong sold shares in NantKwest, a San Diego cancer research firm,...

  • Two more deaths may be linked to contaminated medical scopes

    Two more deaths may be linked to contaminated medical scopes

    Two patients died and six more were sickened in a new outbreak suspected of being caused by contaminated medical scopes, according to a regulatory report by device manufacturer Olympus Corp. The report shows that hospitals are continuing to use a device that was recalled in January, which experts...

Loading
61°